Products

sitegeniebuild

AI-native

Turn dream into reality.

sitegeniebuild.com TelegramSoftware Development / AI App Builders & Low-Code

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Usage-based
No monthly subscription pricing
Launched
5mo ago
2026-06-22 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Build full-stack apps from prompts with AI agents

    Jun 22 · 5mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-05-24

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Starter 50
₹5one-time
50 Tokens
Booster 100
₹10one-time
100 Tokens
Power 150
₹20one-time
150 Tokens
Mega 500
₹50one-time
500 Tokens

Trial: None · Observed 2026-11-06 · Source page

Pages & changes

Tracked since 2026-06-22

Key pages

Weekly snapshots
Home
sitegeniebuild.com/ Snapshot 2026-11-06

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does sitegeniebuild cost?
Starter 50: ₹5one-time; Booster 100: ₹10one-time; Power 150: ₹20one-time; Mega 500: ₹50one-time. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does sitegeniebuild get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is sitegeniebuild and what platforms does it support?
sitegeniebuild is catalogued under AI App Builders & Low-Code: Turn dream into reality.. Supported platforms: Web.

Related products in this category

Software Development / AI App Builders & Low-Code

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.